The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial
-
* Corresponding author: Kenneth Rockwood Kenneth.Rockwood@Dal.ca
BMC Neurology 2007, 7:26 doi:10.1186/1471-2377-7-26
Pre-publication versions of this article and reviewers' reports
| Original Submission - Version 1 | Manuscript | 01 Nov 2006 | |
| Reviewer's Report | Michael WOODWARD | 08 May 2007 | |
| Reviewer's Report | Martin Farlow | 09 May 2007 | |
| Resubmission - Version 2 | Manuscript | Author's comment | 07 Jun 2007 |
| Reviewer's Report | Michael WOODWARD | 11 Jun 2007 | |
| Resubmission - Version 3 | Manuscript | Author's comment | 13 Jul 2007 |
| Resubmission - Version 4 | Manuscript | Author's comment | 25 Jul 2007 |
| Editorial acceptance | 15 Aug 2007 | ||
| Published | 30 Aug 2007 |